Accendra Health
175 hedge funds and large institutions have $322M invested in Accendra Health in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 53 increasing their positions, 55 reducing their positions, and 27 closing their positions.
86% more capital invested
Capital invested by funds: $173M → $322M (+$149M)
2.06% more ownership
Funds ownership: 85.91% → 87.97% (+2.1%)
1% more funds holding
Funds holding: 173 → 175 (+2)
7% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 27
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 55
61% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $4.67M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$8.58M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$4.38M |
| 3 |
D.E. Shaw & Co
New York
|
+$3.59M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.28M |
| 5 |
Renaissance Technologies
New York
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.43M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$4.41M |
| 3 |
Blackstone Inc
New York
|
-$3.73M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.4M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$1.66M |
ACH Hedge Fund Activity: Q3 2019 in Review
175 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q3 2019, worth a combined $322M — up 86% from $173M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new ACH positions and 27 closed out — a net gain of 2 holders — while 53 added to existing stakes and 55 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $8.58M. The largest seller was Morgan Stanley, cutting an estimated $6.43M.
- 175 institutional investors held Accendra Health (ACH) as of Q3 2019, up from 173 in Q2 2019.
- Funds reported $322M of Accendra Health stock for Q3 2019, up 86% quarter-over-quarter.
- 29 funds opened new Accendra Health positions in Q3 2019 and 27 closed out, a net change of +2 holders.
- The largest Accendra Health buyer in Q3 2019 was JP Morgan Chase, an estimated $8.58M added.
- The largest Accendra Health seller in Q3 2019 was Morgan Stanley, an estimated $6.43M sold.
Based on aggregated 13F filings for Q3 2019.